Phenotype of heterozygous familial hypercholesterolemia caused by deletion of <i>LDLR</i> gene exons 2-10: a case report

Phenotype of heterozygous familial hypercholesterolemia caused by deletion of <i>LDLR</i> gene exons 2-10: a case report

Introduction. Analysis and comparison of clinical and functional characteristics of patients with familial hypercholesterolemia (FH) with molecular genetics data make it possible to clarify the disease nature and determine the management strategy taking into account the clinical and genetic status....

Full description

Saved in:

Bibliographic Details
Main Authors:	A. M. Moiseeva, O. N. Ivanova, V. S. Emelyanchik, E. Yu. Emelyanchik, O. V. Marilovtseva, S. Yu. Nikulina, A. V. Protopopov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2024-12-01
Series:	Российский кардиологический журнал
Subjects:	familial heterozygous hypercholesterolemia cardiovascular risk cascade screening for dyslipidemia atherosclerosis coronary artery disease missense mutations deletions low-density lipoproteins.
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5927
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New opportunities for identifying the risk of cardiovascular events in young people: the role of familial hypercholesterolemia
by: V. S. Emelyanchik, et al.
Published: (2023-01-01)

Phenotypical features of heterozygous familial hypercholesterolemia in individuals with LDLR or APOB gene mutations
by: A. N. Meshkov, et al.
Published: (1970-01-01)

Effectiveness of fixed-dose combination of rosuvastatin and ezetimibe in heterozygous familial hypercholesterolemia from the RENAISSANCE registry
by: I. A. Alekseeva, et al.
Published: (2025-08-01)

Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy?
by: Z. D. Kobalava, et al.
Published: (2020-11-01)

Echocardiographic Calcium Score of Aortic Valve Correlates with Coronary Artery Calcium Score in Heterozygous Familial Hypercholesterolemia
by: Angelo Baldassare Cefalù, et al.
Published: (2025-03-01)

Familial hypercholesterolemia: current status of the problem, treatment, and prevention
by: S. A. Bliznyuk, et al.
Published: (2020-11-01)

Glucose metabolism in heterozygous familial hypercholesterolemia with a founder effect and a high diabetes prevalence: a cross-sectional study
by: Ana María González-Lleó, et al.
Published: (2025-08-01)

Familial hypercholesterolemia: case series of a rare condition
by: O. P. Ishevskaia, et al.
Published: (2021-10-01)

CLINICAL APPLICATION OF HELP-APHERESIS IN FEMALE PATIENT WITH FAMILIAL HYPERCHOLESTEROLEMIA
by: OLGA L. Barbarash, et al.
Published: (2018-12-01)

Plant sterols and stanols as dietary factors reducing hypercholesterolemia by inhibiting intestinal cholesterol absorption
by: M. A. Khuchieva, et al.
Published: (2011-12-01)

Familial Hypercholesterolemia in Children. The Current State of the Problem
by: Dinara I. Sadykova, et al.
Published: (2023-07-01)

Prevalence and penetrance of pathogenic and likely pathogenic LDLR and APOB gene variants linked to familial hypercholesterolemia and increased risk of ischemic heart disease
by: I. K. Dzhumaniiazova, et al.
Published: (2025-08-01)

Evaluation of the hypercholesterolemia care cascade and compliance with NCEP-ATP III guidelines in Iran based on the WHO STEPS survey
by: Shirin Djalalinia, et al.
Published: (2025-03-01)

Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council
by: M. V. Ezhov, et al.
Published: (2021-03-01)

Complex topology rather than complex membership is a determinant of protein dosage sensitivity
by: Richard Oberdorf, et al.
Published: (2009-03-01)

Contribution of Rare and Common <i>APOE</i> Variants to Familial Hypercholesterolemia in Spanish Cohort
by: Lorena M. Vega-Prado, et al.
Published: (2025-01-01)

Novel Co‐Occurrence of Trisomy 21 and Heterozygous CFTR Mutation
by: Majd Oweidat, et al.
Published: (2025-04-01)

Organization of lipid centers operation in the Russian Federation — new opportunities
by: M. V. Ezhov, et al.
Published: (2021-07-01)

School-based universal screening for hypercholesterolemia in children
by: Chang-Hsien Yu, et al.
Published: (2022-07-01)

ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I
by: N. M. Akhmedzhanov, et al.
Published: (2015-09-01)

The Role of Red Yeast Rice Based Preparations for Non-Pharmacological Correction of Dyslipidemia in Patients with Low and Moderate Cardiovascular Risk (Expert Opinion)
by: M. V. Ezhov, et al.
Published: (2020-03-01)

Phialophora americana infection in a patient with a compound heterozygous CARD9 mutation
by: Jie Wu, et al.
Published: (2025-04-01)

Outcomes of Dyslipidemia Screening Program in School-aged Children
by: Engin Köse, et al.
Published: (2021-06-01)

ECONOMIC BURDEN OF HYPERCHOLESTEROLEMIA IN THE RUSSIAN FEDERATION
by: A. V. Kontsevaya, et al.
Published: (2018-07-01)

Novel compound heterozygous PIEZO1 variants in dehydrated hereditary stomatocytosis initially suspected as myelodysplastic syndromes: a case report
by: Yongcheng Sun, et al.
Published: (2025-05-01)

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues
by: N. M. Akhmedzhanov, et al.
Published: (2019-01-01)

DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY)
by: A. I. Ershova, et al.
Published: (2015-09-01)

A dietary combination of red yeast rice, phytosterol ester and lycopene ameliorates hypercholesterolemia by regulating gut microbiota and activating hepatic FXR-LDLR/ABCG pathway in mice
by: Jingxian Xu, et al.
Published: (2025-08-01)

Clinical characteristics of carriers of pathogenic LDLR and АРОВ mutations
by: Z. F. Kim, et al.
Published: (2024-02-01)

t-RNA mediates provirus deletion in HIV-infected cells
by: Corrado Gurgo, et al.
Published: (2025-07-01)

Prevalence of familial hypercholesterolemia and hyperlipoproteinemia(a) in patients with premature acute coronary syndrome
by: U. V. Chubykina, et al.
Published: (2022-07-01)

Gender and age features of dyslipidemia in the population of the Nizhny Novgorod region
by: N. Yu. Borovkova, et al.
Published: (2023-11-01)

Chitosan treatment abrogates hypercholesterolemia-induced erythrocyte’s arginase activation
by: Gamaleldin I. Harisa, et al.
Published: (2017-01-01)

Complementizer deletion and the split hypothesis
by: Elena Isolani
Published: (2025-07-01)

5q deletion in childhood T-acute lymphoblastic leukemia at diagnosis: a case report
by: Yousra Sbibih, et al.
Published: (2025-06-01)

A strategy for the execution of copy and delete operations in the tree of objects
by: A. V. Mayorov
Published: (2011-03-01)

Metastatic Pheochromocytoma Diagnosed with 131I-MIBG SPECT/CT Imaging in a Patient with Pathogenic VHL Mutation
by: Kousik Vankadari, et al.
Published: (2022-03-01)

The role of plant stanols in the primary prevention of hypercholesterolemia in patients with arterial hypertension
by: A. S. Safaryan, et al.
Published: (2019-06-01)

22q11.2 Deletion Syndrome: Symptoms, Diagnosis, Treatment
by: Leyla S. Namazova-Baranova, et al.
Published: (2016-12-01)

A Novel 3670-Base Pair Mitochondrial DNA Deletion Resulting in Multi-systemic Manifestations in a Child
by: Hsin-Ming Liu, et al.
Published: (2012-08-01)